Journal article icon

Journal article

Glycaemic Control by Sociodemographic Factors in Adults With Type 1 Diabetes in England: Trends From 2007–2008 to 2023–2024

Abstract:
Aims: This study evaluated trends in glycaemic control in adults with Type 1 diabetes in England from 2007–2008 to 2023–2024, stratified by age, sex, ethnicity and socioeconomic deprivation. Materials and Methods: Adults aged ≥ 20 years from the National Diabetes Audit were analysed. Trends in mean HbA1c were assessed using linear mixed‐effects models. Logistic regression examined associations between sociodemographic factors and having an HbA1c ≤ 58 mmol/mol (≤ 7.5%); odds ratios were converted to relative risks. Results: In 2007–2008, 32.6% of 133 035 adults had an HbA1c ≤ 58 mmol/mol, increasing to 39.1% of 226 005 adults in 2023–2024. Mean HbA1c declined from 68.8 (95% CI: 68.6–69.0) to 66.2 mmol/mol (95% CI: 66.1–66.3). By age, the largest improvement occurred in those aged 20–24 years, from 76.7 to 70.1 mmol/mol (p < 0.001), while adults > 64 years saw a non‐significant increase from 63.7 to 63.8 mmol/mol (p = 0.203). Women consistently had higher mean HbA1c than men (2023–2024: 66.1 vs. 65.8 mmol/mol), declining from 69.4 to 66.1 mmol/mol in women and from 68.4 to 65.8 mmol/mol in men (both p < 0.001) and a lower adjusted probability of threshold attainment (38.4% [95% CI: 38.0–39.4] vs. 38.7% [95% CI: 38.2–39.3]). Marked ethnic inequalities persisted in 2023–2024: mean HbA1c was highest in Black (72.1 mmol/mol, 95% CI: 71.5–72.7) and Asian adults (69.8 mmol/mol, 95% CI: 69.4–70.2) compared with White adults (65.3 mmol/mol, 95% CI: 65.1–65.5). Socioeconomic gradients remained substantial, with threshold attainment at 46.4% (95% CI: 45.6–47.2) in the least deprived versus 32.3% (95% CI: 31.4–33.9) in the most deprived group. Conclusions: Although HbA1c improved overall, inequalities by age and deprivation widened, highlighting the need for equitable targeted care.
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Files:
Publisher copy:
10.1111/dom.70929

Authors

More by this author
Role:
Author
ORCID:
0000-0001-6092-2021
More by this author
Role:
Author
ORCID:
0000-0002-1604-2593


More from this funder
Funder identifier:
https://ror.org/00xm3h672
More from this funder
Funder identifier:
https://ror.org/00datzr31


Publisher:
Wiley
Journal:
Diabetes, Obesity and Metabolism: A Journal of Pharmacology and Therapeutics More from this journal
Article number:
dom.70929
Publication date:
2026-06-01
Acceptance date:
2026-04-29
DOI:
EISSN:
1463-1326
ISSN:
1462-8902


Language:
English
Keywords:
Source identifiers:
4104641
Deposit date:
2026-06-02
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP